Feasibility and Adherence of a Multicomponent Digital Health Monitoring Platform in Ambulatory Heart Failure: Multicenter Observational Study

Background Digital health platforms combining wearable biosensors with smartphone apps offer scalable approaches to heart failure (HF) management, yet sustained patient engagement and initial technology adoption, particularly among older adults, remain uncertain. Objective We conducted a prospective, multicenter observational study to explore the feasibility and adherence of using a digital health monitoring platform for 8 weeks in a population of ambulatory patients with HF. Methods In this prospective multicenter observational study, patients with New York Heart Association (NYHA) class I to III HF were prescreened across 6 institutions in the United States and Singapore. Participants wore an Everion multisensor armband and an Apple Watch continuously and completed daily electrocardiograms (ECGs), daily symptom questionnaires, weekly voice recordings, and biweekly KCCQ-12 (Kansas City Cardiomyopathy Questionnaire-12) assessments. Prespecified end points included recruitment yield, device wear-time, task-specific compliance, dropout rate, and adverse events. Results Of 3386 prescreened individuals, 520 (15.4%) were clinically eligible; 66 consented (1.9% of prescreened; 12.7% of eligible), with technology-related concerns driving most declinations. Among 65 enrolled patients (mean age 56.5, SD 12.3 years; n=53, 81.5% male), 52 (80%) completed 8 weeks. Mean daily wear-time was 11.7 (SD 5.7) hours, significantly exceeding the 8-hour benchmark (P<.001). Task completion rates were 76.6% (2788/3640, daily ECG), 68.5% (2493/3640, daily symptoms), 86.5% (450/520, weekly voice), and 88.1% (229/260, biweekly KCCQ-12). Adherence did not differ significantly by age group (P=.81). No serious device-related adverse events occurred. Conclusions Enrolled patients with HF, including older adults, sustained robust engagement with a multicomponent digital platform over 8 weeks. However, technology-related concerns prevented most eligible patients from enrolling, identifying adoption, not adherence, as the primary barrier to scalable remote monitoring. Trial Registration ClinicalTrials.gov NCT04191356; https://clinicaltrials.gov/study/NCT04191356

Authors

Publication Details

Journal
JMIR Formative Research
Published
2026-11-19
DOI
https://doi.org/10.2196/99974
Primary Topic
Mobile Health and mHealth Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Feasibility and Adherence of a Multicomponent Digital Health Monitoring Platform in Ambulatory Heart Failure: Multicenter Observational Study

Joseph S. Ross, Stephanie J. Zawada, Charles J. Bruce, Christopher John McLeod et al.
JMIR Formative Research
Mobile Health and mHealth Applications
article

Feasibility and Adherence of a Multicomponent Digital Health Monitoring Platform in Ambulatory Heart Failure: Multicenter Observational Study

Joseph S. Ross, Stephanie J. Zawada, Charles J. Bruce, Christopher John McLeod, Felis Dwiyasa, Kuldeepsingh Rajput, Maulik D. Majmudar, Yan He, Hao Chen, Sy Jackie Lou Velarde
article en

Abstract

Background Digital health platforms combining wearable biosensors with smartphone apps offer scalable approaches to heart failure (HF) management, yet sustained patient engagement and initial technology adoption, particularly among older adults, remain uncertain. Objective We conducted a prospective, multicenter observational study to explore the feasibility and adherence of using a digital health monitoring platform for 8 weeks in a population of ambulatory patients with HF. Methods In this prospective multicenter observational study, patients with New York Heart Association (NYHA) class I to III HF were prescreened across 6 institutions in the United States and Singapore. Participants wore an Everion multisensor armband and an Apple Watch continuously and completed daily electrocardiograms (ECGs), daily symptom questionnaires, weekly voice recordings, and biweekly KCCQ-12 (Kansas City Cardiomyopathy Questionnaire-12) assessments. Prespecified end points included recruitment yield, device wear-time, task-specific compliance, dropout rate, and adverse events. Results Of 3386 prescreened individuals, 520 (15.4%) were clinically eligible; 66 consented (1.9% of prescreened; 12.7% of eligible), with technology-related concerns driving most declinations. Among 65 enrolled patients (mean age 56.5, SD 12.3 years; n=53, 81.5% male), 52 (80%) completed 8 weeks. Mean daily wear-time was 11.7 (SD 5.7) hours, significantly exceeding the 8-hour benchmark (P<.001). Task completion rates were 76.6% (2788/3640, daily ECG), 68.5% (2493/3640, daily symptoms), 86.5% (450/520, weekly voice), and 88.1% (229/260, biweekly KCCQ-12). Adherence did not differ significantly by age group (P=.81). No serious device-related adverse events occurred. Conclusions Enrolled patients with HF, including older adults, sustained robust engagement with a multicomponent digital platform over 8 weeks. However, technology-related concerns prevented most eligible patients from enrolling, identifying adoption, not adherence, as the primary barrier to scalable remote monitoring. Trial Registration ClinicalTrials.gov NCT04191356; https://clinicaltrials.gov/study/NCT04191356

JMIR Formative ResearchVol. 10
Mobile Health and mHealth Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon